跳至主要内容
临床试验/ACTRN12626000814370
ACTRN12626000814370招募中不适用

Validation of Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) assays as a traumatic brain injury (TBI) prognostication marker

East Metropolitan Health Service0 个研究点目标入组 100 人开始时间: 2025年2月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • •Patients admitted to the ICU who:
  • •Are less than 24 hours since suffering from a traumatic brain injury
  • •Are expected to stay in the ICU for more than 48 hours
  • •Are between 18 and 80 years old
  • •Have CT brain imaging evidence of presence of traumatic brain injury

排除标准

  • •Conditions which will cause a rise or alterations in GFAP and UCH-L1 levels independent of the TBI:
  • •Spinal Cord Injury (radiological evidence)
  • •A known central nervous system (CNS) and/or paraneoplastic malignancy.
  • •Acute Kidney Injury (Creatinine levels greater than 1.5x baseline) or End-stage renal failure (receives chronic dialysis)
  • •Pre-existing neurodegenerative disease (Parkinson’s, Alzheimer’s, Lewy body, etc.)
  • •Cardiac arrest / suspected hypoxic-ischaemic encephalopathy.
  • •Pregnancy/lactation/=3 months postpartum
  • •Massive transfusion in the previous 12 hours
  • •Conditions that may interefere with the ability to assess outcomes:
  • •Severe pre-existing physical or mental disability or severe comorbidity that may interfere with the assessment of outcome.

研究组 & 干预措施

a) Overview of information collected

干预措施: a) Overview of information collected

研究者

相似试验